Dr. Rosen shares what a patient should know once diagnosed with B-cell lymphoma.
B-cell lymphomas are the most common lymphomas in the United States. They make up about 85 to 90% of non-Hodgkin’s lymphomas in the United States.
A B-cell is a lymphocyte that’s capable of making antibodies, and when alterations occur in the genes of a lymphocyte, they can become malignant, which is cancerous. They then can replicate without control, and this is a lymphoma.
The B-cell malignancies are part of a spectrum of different types of non-Hodgkin’s lymphoma going from the very aggressive to the more indolent in nature. For the majority of B-cell lymphomas, we don’t know the cause. There are some B-cell lymphomas that seem to arise as a result of chronic inflammation and these are often called mucosa-associated lymphoid tumors or MALT tumors.
About Dr. Steven Rosen, M.D., F.A.C.P:
Steven Rosen, M.D., F.A.C.P., is Genevieve Teuton Professor of Medicine, at the Feinberg School of Medicine, Northwestern University and Director of the Robert H. Lurie Comprehensive Cancer Center of Northwestern University and Director of Cancer Programs at Northwestern Memorial Hospital. Following his graduation with distinction from Northwestern University Medical School's Six-Year Honors Program in 1976, Dr. Rosen completed his residency in Internal Medicine at Northwestern and a fellowship in Medical Oncology at the National Cancer Institute. Dr. Rosen's laboratory research focuses on experimental therapeutics and hematologic malignancies.